United States · Platforms & data · MarketBeat
Bioventus Q3 Earnings Call Highlights
Bioventus (NASDAQ:BVS) reported third-quarter revenue growth of 3% as strength in its Pain Treatments business, Ultrasonics operation and international markets was partly offset…
Read the full article on MarketBeat Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)




